Warhound emerges from stealth with $200M to genetically engineer military working dogs, with Anduril gear
Warhound, a startup backed by Colossal Biosciences CEO Ben Lamm and developed in partnership with Anduril (Palmer Luckey), emerged from stealth on 2026-10-22 with $200 million in funding at a $1.2 billion valuation. Investors include In-Q-Tel, Sequoia and 8VC. The company plans to gene-edit and clone working dogs for the U.S. military, la…